AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the technology.
Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for ...
AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the Centers ...
Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including ...
AI reveals hidden patterns in ECGs that human experts can't see, transforming a century-old clinical tool into a powerful ...
The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...
FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections. icotec is honored to be the first and only company in the United States with FDA 510(k) clearance ...
The campaign is supported by AliveCor, whose artificial intelligence-powered electrocardiogram (ECG) technology is used within the NHS to detect abnormal heart rhythms like AF, bradycardia and ...
One competitor is AliveCor. The firm is racking up collaborative projects for its Kardia Mobile device which attaches to the back of a smartphone and allows for real-time heart monitoring at any time.
The global mobile health (mHealth) apps and solutions market is projected to experience significant growth, with a compound annual growth rate (CAGR) of 18.18% ...
Wearable Medical Devices Market is estimated to valued USD 40.13 Bn in 2024 & expected to reach USD 111.20 Bn by 2031, exhibiting CAGR of 15.7% from 2024-2031 ...